These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 2686850)

  • 1. Cisplatin nephrotoxicity. A review.
    Daugaard G; Abildgaard U
    Cancer Chemother Pharmacol; 1989; 25(1):1-9. PubMed ID: 2686850
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial.
    Baek SH; Kim SH; Kim JW; Kim YJ; Lee KW; Na KY
    Trials; 2015 May; 16():239. PubMed ID: 26021829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
    Klöckl MC; Kasparek AK; Riedl JM; Moik F; Mollnar S; Stotz M; Szkandera J; Terbuch A; Gerger A; Niedrist T; Pichler M; Bauernhofer T; Schilcher G; Zitta S; Rosenkranz AR; Friedl C; Stöger H; Posch F
    Sci Rep; 2020 Jul; 10(1):11219. PubMed ID: 32641710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients.
    Ishitsuka R; Miyazaki J; Ichioka D; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Matsui Y; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Kawai K; Nishiyama H
    Clin Exp Nephrol; 2017 Aug; 21(4):732-740. PubMed ID: 27565169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Administration of l-Carnitine and Ascorbic Acid Ameliorates Cisplatin-Induced Nephrotoxicity in Rats.
    Alabi QK; Akomolafe RO; Olukiran OS; Nafiu AO; Adefisayo MA; Owotomo OI; Omole JG; Olamilosoye KP
    J Am Coll Nutr; 2018 Jul; 37(5):387-398. PubMed ID: 29425480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides Restore Functional State of the Kidneys During Cisplatin-Induced Acute Renal Failure.
    Zamorskii II; Shchudrova TS; Lin'kova NS; Nichik TE; Khavinson VKh
    Bull Exp Biol Med; 2015 Oct; 159(6):736-9. PubMed ID: 26515176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study.
    Yoshida T; Niho S; Toda M; Goto K; Yoh K; Umemura S; Matsumoto S; Ohmatsu H; Ohe Y
    Jpn J Clin Oncol; 2014 Apr; 44(4):346-54. PubMed ID: 24503028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity of anticancer treatment.
    Malyszko J; Kozlowska K; Kozlowski L; Malyszko J
    Nephrol Dial Transplant; 2017 Jun; 32(6):924-936. PubMed ID: 28339935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of platelet activating factor in gentamicin and cisplatin nephrotoxicity.
    Dos Santos OF; Boim MA; Barros EJ; Schor N
    Kidney Int; 1991 Oct; 40(4):742-7. PubMed ID: 1745025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal responses to atrial natriuretic peptide (ANP) in rats with non-oliguric acute renal failure induced by cisplatin.
    Nagano N; Yagi M; Kato S; Furuya Y; Miyata S; Manabe N
    J Vet Med Sci; 1995 Dec; 57(6):997-1002. PubMed ID: 8720036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of cisplatin-induced acute renal failure with 8-cyclopentyl-1,3-dipropylxanthine.
    Knight RJ; Collis MG; Yates MS; Bowmer CJ
    Br J Pharmacol; 1991 Dec; 104(4):1062-8. PubMed ID: 1810593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying cisplatin-induced kidney damage in paediatric oncology patients.
    Barton CD; Pizer B; Jones C; Oni L; Pirmohamed M; Hawcutt DB
    Pediatr Nephrol; 2018 Sep; 33(9):1467-1474. PubMed ID: 28821959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin nephrotoxicity: insights into mechanism.
    Safirstein R; Winston J; Moel D; Dikman S; Guttenplan J
    Int J Androl; 1987 Feb; 10(1):325-46. PubMed ID: 3583421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary parameters predictive and electrolyte disturbances of cisplatin-induced acute renal associated with cancer as a critical target of the chemotherapeutic agent in patients with solid tumors.
    Pedram B; Moghadam AT; Kamyabi-Moghaddam Z; Mavedati O; Beigi BA; Sharabiyani AK; Dezfuli AB; Khalili S; Bahrami AM; Nasoori A
    Tumour Biol; 2015 Jun; 36(6):4495-500. PubMed ID: 25596088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of nephrotoxicity induced by cisplatin combination chemotherapy in gastric cancer patients.
    Moon HH; Seo KW; Yoon KY; Shin YM; Choi KH; Lee SH
    World J Gastroenterol; 2011 Aug; 17(30):3510-7. PubMed ID: 21941418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
    Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
    J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower Blood Pressure-Induced Renal Hypoperfusion Promotes Cisplatin-Induced Nephrotoxicity.
    Mizuno T; Hayashi T; Shimabukuro Y; Murase M; Hayashi H; Ishikawa K; Takahashi K; Yuzawa Y; Yamada S; Nagamatsu T
    Oncology; 2016; 90(6):313-20. PubMed ID: 27225867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum creatinine and cystatin C provide conflicting evidence of acute kidney injury following acute ingestion of potassium permanganate and oxalic acid.
    Wijerathna TM; Gawarammana IB; Dissanayaka DM; Palanagasinghe C; Shihana F; Dassanayaka G; Shahmy S; Endre ZH; Mohamed F; Buckley NA
    Clin Toxicol (Phila); 2017 Nov; 55(9):970-976. PubMed ID: 28535124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
    Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
    BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of theophylline in preventing cisplatin-related nephrotoxicity in patients with cancer.
    Karademir LD; Dogruel F; Kocyigit I; Yazici C; Unal A; Sipahioglu MH; Oymak O; Tokgoz B
    Ren Fail; 2016 Jun; 38(5):806-14. PubMed ID: 27049176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.